Edward J. Handler, III, Esq.
Mr. Handler, a former senior partner and of counsel, Kenyon & Kenyon, LLP, has worked on pharmaceutical intellectual property cases over the years. He has been responsible for assembling the TBP Pharma management team and for assembling the necessary consulting, licensing and IP agreements relating to C3.
Mary Jane D. O’Connell, Ph.D., Esq
Chief Executive Officer and Board Member
Dr. O’Connell holds a B.S. in biological sciences from Fordham University, M.S. in natural sciences/chemistry and Ph.D. in chemistry/immunology from Roswell Park Cancer Institute, Buffalo, NY. Dr. O’Connell received her NIH NRSA postdoctoral training in immunology and molecular biology at NY Medical College and in immunochemistry at Memorial Sloan-Kettering Cancer Center where she was associated professionally for ten years as a cancer research scientist and senior research administrator. Following her J.D. from Fordham University School of Law, she was associated with Kenyon & Kenyon, LLP in pharmaceutical patent practice. Dr. O’Connell expects her MBA and M.S. in Healthcare Leadership degrees from Cornell University Johnson Graduate School of Management and Weill Cornell Medical College in 2019, bringing her expertise to focus on commercializing C3.
Joseph E. Root, Esq.
General Counsel, Secretary and Board Member
Mr. Root is an attorney with 30 years of experience developing, protecting, and exploiting patent portfolios. He is the author of “Rules of Patent Drafting: Guidelines from Federal circuit Case Law”, published by Oxford University Press in 2011.
Mr. Green has over 17 years of experience in business development, finance and strategy. While CEO of BREONICS, a Medical Device company in the Regenerative Medicine space, he led the company as it prepared for clinical trials. Previously, he served as a strategy consultant for Deloitte’s Strategy and Operations Practice where he advised C-Level executives on supply chain, logistics, manufacturing and turnarounds.
John F. Bronzo, Esq.
Vice President Business Development & Strategy and Board Member